Have you been histologically or cytologically confirmed to have Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma that is considered incurable by local therapies? If so, you may be able to participate in a research study seeking to find out if Amivantamab Monotherapy and/or Amivantamab in Addition to Standard of Care Therapeutic Agents can be an effective traetment.

Are you an adult between the ages of 18 and 35? Are you interested in brain research? If so, you may be able to participate in a study to see how people see social interactions in different situations. Compensation provided.

The study is researching an experimental drug called dupilumab. The study is focused on participants with active eosinophilic gastritis (EoG) with or without eosinophilic duodenitis (EoD). Participants with EoD only are not eligible for enrollment. EoG and EoD are uncommon, persistent, allergic/immune diseases in which eosinophils (a type of white blood cell) gather in large numbers in the stomach and small intestine and cause inflammation and damage.

In this study, we want to compare a new drug for multiple sclerosis (MS) with a drug that is already being used. We want to see how the new drug works and if it might be a better option for treating MS.

The purpose of this study is to determine the efficacy of lactoferrin supplementation on iron regulation, gut health, immune function and physical activity performance.

My name is Halden Levin, and I am an undergraduate Linguistics major. For my honors thesis, I am investigating factors influencing speech production and perception in American English and Taiwanese Mandarin. Researching these factors will allow us to better understand speech production and perception.

The goal of this study is to understand how community and social connections may serve as protective factors for suicidal thoughts and behaviors in autistic and non-autistic individuals ages 55 and older. We aim to understand how both in-person and online social connections are associated with suicidal thoughts and behaviors. While a history of mental health concerns is required to participate in this study, a history of suicidal thoughts and behaviors is not required.

Have you been diagnosed with Chronic Myeloid Leukemia, have a T315I mutation, and previously treated with at least two tyrosine kinase inhibitors (TKIs)? You might be able to participate in this study.

We are studying an investigational drug, Efruxifermin, to see if it will help in the treatment of liver inflammation and scarring (fibrosis) in adults diagnosed with NASH (non-alcoholic steatohepatitis) and MASH (metabolic dysfunction-associated steatohepatitis).

The purpose of this research study is to compare the effectiveness of two combinations of anticancer study drugs in treating your Chronic Lymphocytic Leukemia (CLL). The first combination is sonrotoclax (also known as BGB-11417) and zanubrutinib, while the second combination is venetoclax and obinutuzumab. The aim is to determine which combination of study drugs is more effective in controlling your specific type of cancer,